Centene Projects FY Revenue of $193.5B-$197.5B, Topping Views
CNC has more than doubled off its 52-week low of $25.075.
Summary
Centene issued full-year revenue guidance of $193.5 billion to $197.5 billion, exceeding consensus expectations. The company also raised its 2026 outlook, projecting premium and service revenue of $173 billion to $177 billion, a health benefits ratio of 90.5% to 91.3%, adjusted EPS above $4.80, and EPS above $3.11. The improved forecast follows second-quarter profit and revenue growth that beat estimates. The outlook comes amid aggressive staff buyouts and declining commercial membership, with the company leaning on pricing and government contract wins, including an Illinois Medicaid contract and planned Obamacare premium increases in 2027, to drive top-line growth.
At the time of this announcement, CNC was trading at $67.38 on NYSE in the Life Sciences sector, with a market capitalization of approximately $31.6B. The 52-week trading range was $25.08 to $69.36. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.